| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2017/04/20 | 19:04 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/14 | 05:37 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/06 | 20:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/03 | 05:57 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/03 | 05:55 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/03 | 05:51 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/03 | 01:32 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 07:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 06:56 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 06:50 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 05:36 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02:32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02:30 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02:19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02:15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/01 | 23:52 | PR Newswire (US) | Lilly Completes Acquisition of CoLucid Pharmaceuticals | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/01 | 23:41 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/01 | 22:45 | PR Newswire (US) | Lilly Completes Acquisition of CoLucid Pharmaceuticals | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/01 | 20:31 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/01 | 20:18 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/02/15 | 02:33 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/02/15 | 01:58 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/02/15 | 01:15 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/02/11 | 06:32 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/02/11 | 05:39 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |